EXPE
88
-3
MMM
59
-5
STX
82
-6
CINF
60
2
CVS
50
-3
AXP
69
-4
APD
54
2
BIIB
66
3
INTC
68
6
MLM
64
-8
NVDA
59
3
GOOGL
51
3
FLS
61
-3
NOC
61
-9
LMT
64
-10
DVA
38
-3
BRK.B
40
-2
PWR
63
-3
CSCO
53
-3
AVB
22
-5
EXPE
88
-3
MMM
59
-5
STX
82
-6
CINF
60
2
CVS
50
-3
AXP
69
-4
APD
54
2
BIIB
66
3
INTC
68
6
MLM
64
-8
NVDA
59
3
GOOGL
51
3
FLS
61
-3
NOC
61
-9
LMT
64
-10
DVA
38
-3
BRK.B
40
-2
PWR
63
-3
CSCO
53
-3
AVB
22
-5
Financhill
Back

Crinetics Pharmaceuticals, Inc. Stock Predictions

The Next Gold Rush

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
38

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$53.22
Seasonality Move:
-13.28%

7 Day Trial

ALL ACCESS PASS

$ 7

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at

Crinetics Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 19.3% based on the past 7 years of stock performance.
  • Crinetics Pharmaceuticals, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%
  • Is Crinetics Pharmaceuticals, Inc. Stock Undervalued?
    The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.34. The Score for CRNX is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Crinetics Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Crinetics Pharmaceuticals, Inc. has on average historically risen by 19.3% based on the past 7 years of stock performance.

Crinetics Pharmaceuticals, Inc. Stock Rating

Sell
38
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. overpriced?

  • Crinetics Pharmaceuticals, Inc. has risen higher in 3 of those 7 years over the subsequent 52-week period, corresponding to a historical accuracy of 42.86%

Crinetics Pharmaceuticals, Inc. Stock Price History

Is CRNX stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
crinetics.com

52-Week Data

52-Week High:
57.99
52-Week Low:
24.10

Prediction Charts

Market Cap:
5.1B
Price in USD:
53.34
Volume:
4.9M
Beta:
0.68

Technical Analysis

SMA50:
45.42
SMA100:
41.14
SMA200:
36.00
52-Wk Change:
7.93%

Stock Predictions

  • Is Crinetics Pharmaceuticals, Inc. stock public?
    Yes, Crinetics Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Crinetics Pharmaceuticals, Inc. stock quote today?
    The Crinetics Pharmaceuticals, Inc. stock price is 53.34 USD today.
  • How to buy Crinetics Pharmaceuticals, Inc. stock online?
    You can buy Crinetics Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-16 49.78 48.61 50.19 48.36
Dec-17 48.97 47.69 49.14 47.40
Dec-18 47.34 45.14 47.98 43.04
Dec-19 45.31 48.01 49.00 45.07
Dec-22 47.87 49.24 49.75 47.56
Dec-23 48.81 48.87 49.40 48.61
Dec-24 48.91 48.71 49.61 48.52
Dec-26 48.26 47.96 48.41 47.80
Dec-29 47.68 47.52 48.24 47.12
Dec-30 47.66 47.39 48.25 47.04
Dec-31 46.98 46.55 47.36 46.43
Jan-5 55.00 48.18 57.99 46.86
Jan-6 47.40 45.95 48.25 43.40
Jan-7 51.24 53.34 53.97 49.72

Crinetics Pharmaceuticals, Inc. Earnings

Crinetics Pharmaceuticals, Inc. Earnings Report: Per Share Crinetics Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Crinetics Pharmaceuticals, Inc. Forecast Revenue Growth

Crinetics Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Crinetics Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.55 per share.

* Crinetics Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.